The benefits of inspiratory muscle training (IMT) have been reported in neuromuscular diseases. However, its effects are limited. Further research is needed in new and complementary modalities demonstrating IMT efficacy in neuromuscular diseases. This study aimed to investigate the effect of combined IMT and manual therapy in neuromuscular diseases. Twenty-eight children with a diagnosis of muscle disease were included in the study. Only conventional physiotherapy program was applied to the control group. In the study group, in addition to the conventional physiotherapy program, manual therapy techniques were applied 3 days a week and IMT 2 times a day, 5 days a week for 6 weeks. Lung function test, respiratory muscle strength, fatigue and dyspnea assessment, corbin posture analysis, sit-reach test, functional reach test (FRT), timed up and go test (TUG), motor function measure (MFM) and trunk impairment scale (TIS) were used in the evaluations.
Age range
7 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Respiratory Muscle Strength
Timeframe: Baseline and end of Week 6
Peak flow rate (PEF)
Timeframe: Baseline, end of Week 3 and end of Week 6
Forced expiratory volume in the first second (FEV1)
Timeframe: Baseline, end of Week 3 and end of Week 6
Forced vital capacity (FVC)
Timeframe: Baseline, end of Week 3 and end of Week 6
FEV1/FVC
Timeframe: Baseline, end of Week 3 and end of Week 6
Fatigue and Dyspnea
Timeframe: Baseline and end of Week 6
Posture assessment
Timeframe: Baseline and end of Week 6
Motor Function Measure (MFM):
Timeframe: Baseline and end of Week 6